Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basak Coskun

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Dermatology : EJD|March 11, 2005
Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligoBasak Coskun, Yunus Saral, Dilara Turgut
The Journal of Dermatology|October 20, 2004
Benign cutaneous Degos' disease: a case report and review of the literatureBasak Coskun, Yunus Saral, Demet Cicek, et al.
Mycopathologia|October 19, 2004
Sporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literatureBasak Coskun, Yunus Saral, Nusret Akpolat, et al.
Skinmed|November 12, 2005
Activation markers in Behçet's diseaseBasak Coskun, Yunus Saral, Ahmet Gödekmerdan, et al.
Nature Communications|May 10, 2024
Discovering allatostatin type-C receptor specific agonistsKübra Kahveci, Mustafa Barbaros Düzgün, Abdullah Emre Atis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|March 11, 2005
Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligoBasak Coskun, Yunus Saral, Dilara Turgut
The Journal of Dermatology|October 20, 2004
Benign cutaneous Degos' disease: a case report and review of the literatureBasak Coskun, Yunus Saral, Demet Cicek, et al.
Mycopathologia|October 19, 2004
Sporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literatureBasak Coskun, Yunus Saral, Nusret Akpolat, et al.
Skinmed|November 12, 2005
Activation markers in Behçet's diseaseBasak Coskun, Yunus Saral, Ahmet Gödekmerdan, et al.
Nature Communications|May 10, 2024
Discovering allatostatin type-C receptor specific agonistsKübra Kahveci, Mustafa Barbaros Düzgün, Abdullah Emre Atis, et al.
Pageof 1